Navigation Links
ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011
Date:4/29/2011

RANCHO CORDOVA, Calif., April 29, 2011 /PRNewswire/ -- ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fiscal third quarter ended March 31, 2011, on Thursday, May 5, 2011.

Company's Conference Call and Webcast

Management will host a conference call Thursday, May 5, 2011 at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal third quarter financial results.  

The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. J. Melville Engle, Chairman and Chief Executive Officer and Mr. Matthew Plavan, Chief Financial Officer and Executive Vice President, Business Development will host the call to discuss the third quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately 5 minutes before the conference call begins.  

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

Replay

A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted '385107'.

About ThermoGenesis Corp.

ThermoGenesis Corp. (www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

This press release cont
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ThermoGenesis Announces Registration of Res-Q in India; Commercial Sales Expected to Begin in Current Quarter
2. Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies
3. ThermoGenesis Reports Second Quarter 2011 Results; Increased Presence in China
4. ThermoGenesis Announces Agreement for AXP and BioArchive Cord Blood Systems With Major Chinese Stem Cell Company
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2011 Results on February 10, 2011
6. ThermoGenesis Corp. and TotipotentSC Receive Approval for Phase Ib Clinical Trial of Res-Q™ 60 BMC for Treatment of Critical Limb Ischemia
7. ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3
8. ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China
9. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
10. ThermoGenesis Corp. to Announce First Quarter Fiscal 2011 Results on November 4, 2010
11. ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... May 22, 2013  The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®.  The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...
... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance).  The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...
Cached Medicine Technology:The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 2New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 3New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 4New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 5New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 7New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 8New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 9New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 10
(Date:5/23/2013)... (PRWEB) May 23, 2013 As Stryker ... Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount ... new research has found a connection between the type of ... The study, which was published on May 15th in ... hips in 11 patients who reported new-onset and increasing ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Diabetes is ... it can become a nuisance when patients are unfortunate ... According to the National Diabetes Information Clearinghouse at ... at a risk of developing neuropathy which further shrivels ... lives of such patients. Such nerve damage affects the ...
(Date:5/23/2013)... SLEEPY HOLLOW, NY (PRWEB) May 23, 2013 ... joined the staff of Phelps Memorial Hospital Center as ... She will direct comprehensive inpatient and outpatient rehabilitation ... life. , Dr. Liu received her undergraduate degree in ... Scholar for four years. She earned her medical ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Statins are proven ... the medications also could hamper heart patients, ability to ... A small group of overweight or obese people were ... a 40 milligram daily dose of simvastatin, while another ... exercise regimen did show improvement, found the study released ...
(Date:5/23/2013)... (May 23, 2013) -- Little is known about why ... response to treatments varies between patients. Now, a team ... Medical Center and SUNY Downstate Medical Center has revealed ... showing that it is very different from other asthma ... , reveals that an over-active gene linked in 20 ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 3
... Johna Burke will describe communication tactics that can ... delivered on Tuesday, Jan. 6, at a professional ... of the International Association of Business Communicators (IABC). ... website ( www.sc-iabc.com ) or from Stefanie Caraviello ...
... Care Action Network (SCAN(R)) Health Plan Arizona, a nonprofit Medicare ... to train more than 60 seasoned van drivers about what ... a senior." SCAN has been focused on the unique needs ... to enhancing awareness and skills in the community in dealing ...
... Calif., January 5, 2008Scientists at Burnham Institute for Medical ... protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring ... DNA repair. Since Ddk is often deregulated in human ... damage control could help shape new cancer therapies. The ...
... 5, 2009 Only 17 percent of Spanish-speaking women ... a multivitamin containing folic acid daily, according to the ... on this population. , Folic acid can prevent ... brain and spine such as spina bifida and anencephaly, ...
... experts at the University of Cincinnati (UC) have identified a ... drug therapies to combat lung cancer. , The study, led ... of Molecular and Cellular Biology . , Proto-oncogenes ... (turnover of cells and tissue) but, when genetically modified, can ...
... ignition gadget prevents calls or texting while driving , , ... that prevents teens from talking on cell phones or ... of Utah researchers. , The Key2SafeDriving system includes ... connects wirelessly with the user,s cell phone via either ...
Cached Medicine News:Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 2Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 3Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 2Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 3Health News:Burnham researchers illuminate mechanisms that regulate DNA damage control and replication 2Health News:Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says 2Health News:Cell biologists identify new tumor suppressor for lung cancer 2Health News:Car Key Device Jams Teens' Cell Phones 2
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Inquire...
... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
... PRISM 7000 Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... accumulated PCR product is made possible ... and application-specific software in a single ...
Medicine Products: